Skip to content

American Healthcare REIT

US · AHR #1336 by market cap Listed 2024
57.54 -0.07 -0.12%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:01

Recent news

  • Company notice
    American Healthcare REIT | 8-K: American Healthcare REIT (“AHR”) Announces Second Quarter 2025 Results; Increases Full Year 2025 Guidance
    SEC · 2025/8/8
  • Company notice
    American Healthcare REIT | 8-K: American Healthcare REIT (“AHR”) Announces Fourth Quarter 2024 and Full Year 2024 Results; Issues Full Year 2025 Guidance
    SEC · 2025/2/28
  • UBS Maintains American Healthcare REIT(AHR.US) With Buy Rating, Raises Target Price to $71
    Market Newswire · 2026/11/11
  • Citi Maintains American Healthcare REIT(AHR.US) With Buy Rating, Raises Target Price to $67
    Market Newswire · 2026/11/10
  • BofA Securities Maintains American Healthcare REIT(AHR.US) With Buy Rating, Announces Target Price $74
    Market Newswire · 2026/11/13
  • Rating change
    Barclays Maintains American Healthcare REIT(AHR.US) With Buy Rating, Cuts Target Price to $60
    Market Newswire · 2026/10/13
  • Rating change
    Scotiabank Maintains American Healthcare REIT(AHR.US) With Buy Rating, Raises Target Price to $62
    Market Newswire · 2026/9/2
  • Rating change
    Barclays Sticks to Their Buy Rating for American Healthcare REIT, Inc. (AHR)
    TipRanks · 2026/10/13
  • Company notice
    American Healthcare REIT | 8-K: American Healthcare REIT (“AHR”) Announces Fourth Quarter 2025 and Full Year 2025 Results; Issues Full Year 2026 Guidance
    SEC · 2026/2/27
  • Rating change
    Barclays Maintains American Healthcare REIT(AHR.US) With Buy Rating, Raises Target Price to $66
    Market Newswire · 2026/8/31
  • Company notice
    American Healthcare REIT | 8-K: American Healthcare REIT (“AHR”) Announces First Quarter 2025 Results; Increases Full Year 2025 Guidance
    SEC · 2025/5/9
  • Company notice
    American Healthcare REIT | 8-K: American Healthcare REIT (“AHR”) Announces Third Quarter 2025 Results; Increases Full Year 2025 Guidance
    SEC · 2025/11/7
  • Scotiabank Maintains American Healthcare REIT(AHR.US) With Buy Rating, Maintains Target Price $62
    Market Newswire · 2026/11/6
  • Rating change
    Barclays Remains a Buy on American Healthcare REIT, Inc. (AHR)
    TipRanks · 2026/8/31
  • Rating change
    UBS Maintains American Healthcare REIT(AHR.US) With Buy Rating, Cuts Target Price to $62
    Market Newswire · 2026/10/13
  • Rating change
    BMO Capital Maintains American Healthcare REIT(AHR.US) With Buy Rating, Raises Target Price to $65
    Market Newswire · 2026/10/2
  • Rating change
    Raymond James Initiates American Healthcare REIT(AHR.US) With Buy Rating, Announces Target Price $62
    Market Newswire · 2026/10/13
  • KeyBanc Maintains American Healthcare REIT(AHR.US) With Buy Rating
    Market Newswire · 2026/11/16
  • Rating change
    RBC Capital Maintains American Healthcare REIT(AHR.US) With Buy Rating, Raises Target Price to $66
    Market Newswire · 2026/11/10
  • Rating change
    BofA Securities Maintains American Healthcare REIT(AHR.US) With Buy Rating
    Market Newswire · 2026/9/15
  • Rating change
    KeyBanc Sticks to Their Buy Rating for American Healthcare REIT, Inc. (AHR)
    TipRanks · 2026/8/19
  • Adial Pharmaceuticals Appoints David Rubenstein, M.D., Ph.D., as Chief Scientist to Advance Its Colon-Targeted AhR Agonist, AT177, for Ulcerative Colitis
    GlobeNewswire · 2026/10/16
  • Rating change
    UBS Remains a Buy on American Healthcare REIT, Inc. (AHR)
    TipRanks · 2026/8/21
  • Rating change
    KeyBanc Maintains American Healthcare REIT(AHR.US) With Buy Rating, Raises Target Price to $68
    Market Newswire · 2026/8/19
  • Rating change
    UBS Maintains American Healthcare REIT(AHR.US) With Buy Rating, Maintains Target Price $63
    Market Newswire · 2026/8/21

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-11-20 20:01:32 · For reference only, not investment advice and not tailored to your situation.

American Healthcare REIT discussion 0 comments

Add a comment